About us Pricing ContactSubscribe

C

Changli Wang

Tianjin Medical University Cancer Institute and HospitalORCID https://orcid.org/0000-0003-0482-5889

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

The Lancet Oncology20114,075 citations

Changli Wang · Scinovex